Endo International plc

0.3831+0.0154+4.19%Vol 19.94M1Y Perf -92.53%
Jun 27th, 2022 16:00 DELAYED
BID0.3810 ASK0.3846
Open0.3933 Previous Close0.3677
Pre-Market- After-Market0.39
 - -  0.01 1.80%
Target Price
2.25 
Analyst Rating
Moderate Sell 4.50
Potential %
487.31 
Finscreener Ranking
★★★+     52.30
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     52.48
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     54.41
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.52 
Earnings Rating
Strong Sell
Market Cap85.47M 
Earnings Date
4th Aug 2022
Alpha-0.03 Standard Deviation0.26
Beta1.12 

Today's Price Range

0.37500.4030

52W Range

0.28007.07

5 Year PE Ratio Range

-1.1013.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
13.01%
1 Month
-18.49%
3 Months
-84.23%
6 Months
-90.42%
1 Year
-92.53%
3 Years
-90.70%
5 Years
-96.67%
10 Years
-98.74%

TickerPriceChg.Chg.%
ENDP0.38310.01544.19
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 20220.440.6650.00
Q04 20210.700.8420.00
Q03 20210.460.8073.91
Q02 20210.420.6554.76
Q01 20210.480.7352.08
Q04 20200.500.7550.00
Q03 20200.140.52271.43
Q02 20200.350.6585.71
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.15-131.92Negative
9/2022 QR0.13-59.38Negative
12/2022 FY0.79-51.23Negative
12/2023 FY0.29-74.11Negative
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.15
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume19.94M
Shares Outstanding223.10K
Shares Float168.86M
Trades Count25.96K
Dollar Volume7.74M
Avg. Volume24.12M
Avg. Weekly Volume31.26M
Avg. Monthly Volume26.41M
Avg. Quarterly Volume14.67M

Endo International plc (NASDAQ: ENDP) stock closed at 0.3831 per share at the end of the most recent trading day (a 4.19% change compared to the prior day closing price) with a volume of 19.94M shares and market capitalization of 85.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 3397 people. Endo International plc CEO is Blaise Coleman.

The one-year performance of Endo International plc stock is -92.53%, while year-to-date (YTD) performance is -89.81%. ENDP stock has a five-year performance of -96.67%. Its 52-week range is between 0.28 and 7.0652, which gives ENDP stock a 52-week price range ratio of 1.52%

Endo International plc currently has a PE ratio of -0.10, a price-to-book (PB) ratio of 2.64, a price-to-sale (PS) ratio of 0.03, a price to cashflow ratio of 0.20, a PEG ratio of 2.32, a ROA of -8.47%, a ROC of -% and a ROE of 77.45%. The company’s profit margin is -24.74%, its EBITDA margin is 11.80%, and its revenue ttm is $2.93 Billion , which makes it $12.45 revenue per share.

Of the last four earnings reports from Endo International plc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.15 for the next earnings report. Endo International plc’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Endo International plc is Moderate Sell (4.5), with a target price of $2.25, which is +487.31% compared to the current price. The earnings rating for Endo International plc stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Endo International plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Endo International plc has a Sell technical analysis rating based on Technical Indicators (ADX : 20.16, ATR14 : 0.09, CCI20 : -37.96, Chaikin Money Flow : -0.24, MACD : -0.20, Money Flow Index : 38.32, ROC : -16.43, RSI : 31.24, STOCH (14,3) : 30.45, STOCH RSI : 0.87, UO : 36.85, Williams %R : -69.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Endo International plc in the last 12-months were: Blaise A. Coleman (Option Excercise at a value of $0), Mark Bradley (Option Excercise at a value of $0), Matthew J. Maletta (Option Excercise at a value of $0), Patrick Barry (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
4 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
3 (75.00 %)
3 (75.00 %)
2 (33.33 %)
Summary RatingModerate Sell
4.50
Moderate Sell
4.50
Moderate Sell
3.67

Endo International plc

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

CEO: Blaise Coleman

Telephone: +353 12682000

Address: Simmonscourt Road, Ballsbridge, Dublin 4, , IE

Number of employees: 3 397

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

50%50%

News

Stocktwits